Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
The Journal of Infectious Diseases|March 27, 2019
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse ModelAnwar M Hashem, Abdullah Algaissi, Anurodh Shankar Agrawal, et al.Journal of Infection and Public Health|February 2, 2020
Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011-2016Afnan A Degnah, Sawsan S Al-Amri, Ahmed M Hassan, et al.Journal of Immunological Methods|January 20, 2019
Development and validation of different indirect ELISAs for MERS-CoV serological testingAnwar M Hashem, Sawsan S Al-Amri, Tagreed L Al-Subhi, et al.Pathogens (Basel, Switzerland)|December 23, 2020
Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 AntibodiesAnwar M Hashem, Rowa Y Alhabbab, Abdullah Algaissi, et al.Vaccines|August 28, 2021
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1Khalid A Alluhaybi, Rahaf H Alharbi, Rowa Y Alhabbab, et al.Viruses|August 10, 2021
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi ArabiaRowa Y Alhabbab, Ahdab Alsaieedi, Abdullah Algaissi, et al.Antibody Therapeutics|February 19, 2024
ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaksMohamed A Alfaleh, Reem M Alsulaiman, Sarah A Almahboub, et al.Frontiers in Immunology|December 27, 2023
Robust memory humoral immune response to SARS-CoV-2 in the tonsils of adults and childrenTarfa A Altorki, Rwaa H Abdulal, Bandar A Suliman, et al.Journal of Medical Virology|June 23, 2026
Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic CoronavirusesAssala Helal, Najwa D Aljehani, Aishah Ghazwani, et al.Frontiers in Immunology|January 31, 2022
DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster ModelLevi A Tamming, Diana Duque, Anh Tran, et al.Pageof 3